Dean S. Tai
79 Ayer Rajah Crescent
Singapore, 139955, Singapore
Singapore, 139955, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Steatosis in Cirrhosis: A Prognostic Marker for Liver-Related Outcomes in Metabolic-Dysfunction Associated Steatotic Liver Disease.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 12, 2026
Steatosis in Cirrhosis: A Prognostic Marker for Liver-Related Outcomes in Metabolic-Dysfunction Associated Steatotic Liver Disease.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 12, 2026
Real-World Insights in Designing SteatoStat: An End-to-End Deep Learning Pipeline for Hepatic Steatosis Quantification.
Journal: Diagnostics (Basel, Switzerland)
Published: January 28, 2026
Reply to Comments for 'Appraisal of AI-Based Fibrosis Quantification in MASH'.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 09, 2025
Quantitative regression of qFibrosis with resmetirom: Exploratory histologic endpoints from the MAESTRO-NASH phase III clinical trial.
Journal: Journal of hepatology
Published: July 14, 2025
Development of AI Based Fibrosis Detection Algorithm by SHG/TPEF Microscopy for Fully Quantified Liver Fibrosis Assessment in MASH.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 22, 2025
Effect of liver biopsy size on MASLD fibrosis assessment by second-harmonic generation/two-photon excitation fluorescence microscopy.
Journal: JHEP reports : innovation in hepatology
Published: March 17, 2025
Repeatability and Reproducibility of Artificial Imaging-based Digital Pathology for the Evaluation of Liver Fibrosis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 03, 2024
Liver fibrosis progression analyzed with AI predicts renal decline.
Journal: JHEP reports : innovation in hepatology
Published: October 16, 2024
A phase IIb randomised-controlled trial of the FFAR1/FFAR4 agonist icosabutate in MASH.
Journal: Journal of hepatology
Published: July 23, 2024
AI Digital Pathology Using qFibrosis Shows Heterogeneity of Fibrosis Regression in Patients with Chronic Hepatitis B and C with Viral Response.
Journal: Diagnostics (Basel, Switzerland)
Published: July 22, 2024
Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH.
Journal: Journal of hepatology
Published: July 22, 2024
Last Updated: 09/26/2026